Help -
We updated the design of this site on December 18, 2017. Learn more.


A process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial. One of several Study Types.

For more information on expanded access programs, visit the FDA Understanding Expanded Access/Compassionate Use Web site.